Amy W. Rachfal

765 total citations
10 papers, 630 citations indexed

About

Amy W. Rachfal is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Amy W. Rachfal has authored 10 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Amy W. Rachfal's work include Connective Tissue Growth Factor Research (4 papers), Liver physiology and pathology (2 papers) and Systemic Sclerosis and Related Diseases (2 papers). Amy W. Rachfal is often cited by papers focused on Connective Tissue Growth Factor Research (4 papers), Liver physiology and pathology (2 papers) and Systemic Sclerosis and Related Diseases (2 papers). Amy W. Rachfal collaborates with scholars based in United States and Netherlands. Amy W. Rachfal's co-authors include David R. Brigstock, Hay-Oak Park, Pil Jung Kang, Stanley S. Schwartz, Abigail E. Martin, Guliang Xia, Gail E. Besner, Mark Luquette, Conor P. Delaney and Melinda M. Gibbons and has published in prestigious journals such as Journal of Biological Chemistry, Annals of Surgery and Journal of Clinical Pathology.

In The Last Decade

Amy W. Rachfal

10 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy W. Rachfal United States 8 426 115 92 85 70 10 630
Runping Gao China 11 504 1.2× 107 0.9× 87 0.9× 162 1.9× 107 1.5× 34 765
Joon-Il Jun United States 6 273 0.6× 51 0.4× 72 0.8× 80 0.9× 30 0.4× 7 602
Mary Ann S. Crissey United States 14 348 0.8× 196 1.7× 144 1.6× 242 2.8× 109 1.6× 22 783
Huilin Jin China 15 276 0.6× 65 0.6× 49 0.5× 49 0.6× 38 0.5× 26 508
M.T. Jackson Australia 9 398 0.9× 57 0.5× 190 2.1× 92 1.1× 39 0.6× 10 795
Kristin Wahl Germany 10 166 0.4× 150 1.3× 232 2.5× 84 1.0× 72 1.0× 10 518
Jinqiang Zhang United States 16 600 1.4× 63 0.5× 98 1.1× 155 1.8× 26 0.4× 35 919
Marco A. Briones‐Orta Mexico 12 237 0.6× 66 0.6× 69 0.8× 44 0.5× 31 0.4× 17 410
Nian‐Ling Zhu United States 12 392 0.9× 237 2.1× 304 3.3× 139 1.6× 119 1.7× 13 832
Shirley Abramovitch Israel 13 325 0.8× 131 1.1× 236 2.6× 124 1.5× 133 1.9× 15 804

Countries citing papers authored by Amy W. Rachfal

Since Specialization
Citations

This map shows the geographic impact of Amy W. Rachfal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy W. Rachfal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy W. Rachfal more than expected).

Fields of papers citing papers by Amy W. Rachfal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy W. Rachfal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy W. Rachfal. The network helps show where Amy W. Rachfal may publish in the future.

Co-authorship network of co-authors of Amy W. Rachfal

This figure shows the co-authorship network connecting the top 25 collaborators of Amy W. Rachfal. A scholar is included among the top collaborators of Amy W. Rachfal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy W. Rachfal. Amy W. Rachfal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Schwartz, Stanley S., Amy W. Rachfal, & Barbara E. Corkey. (2021). The time is now for new, lower diabetes diagnostic thresholds. Trends in Endocrinology and Metabolism. 33(1). 4–7. 5 indexed citations
2.
Rachfal, Amy W., Struan F.A. Grant, & Stanley S. Schwartz. (2021). The Diabetes Syndrome – A Collection of Conditions with Common, Interrelated Pathophysiologic Mechanisms. International Journal of General Medicine. Volume 14. 923–936. 6 indexed citations
3.
Rachfal, Amy W., et al.. (2020). <p>Diabetes and Psoriasis: Different Sides of the Same Prism</p>. Diabetes Metabolic Syndrome and Obesity. Volume 13. 3571–3577. 23 indexed citations
4.
Delaney, Conor P., Melinda M. Gibbons, Amy W. Rachfal, et al.. (2012). Evaluation of Clinical Outcomes With Alvimopan in Clinical Practice. Annals of Surgery. 255(4). 731–738. 43 indexed citations
5.
Rachfal, Amy W. & David R. Brigstock. (2005). Structural and Functional Properties of CCN Proteins. Vitamins and hormones. 70. 69–103. 144 indexed citations
6.
Rachfal, Amy W., Mark Luquette, & David R. Brigstock. (2004). Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. Journal of Clinical Pathology. 57(4). 422–425. 19 indexed citations
7.
Xia, Guliang, Amy W. Rachfal, Abigail E. Martin, & Gail E. Besner. (2003). Upregulation of Endogenous Heparin-Binding EGF-Like Growth Factor (HB-EGF) Expression after Intestinal Ischemia/Reperfusion Injury. Journal of Investigative Surgery. 16(2). 57–63. 30 indexed citations
8.
Rachfal, Amy W., et al.. (2003). The heparin-binding 10 kDa fragment of connective tissue growth factor (CTGF) containing module 4 alone stimulates cell adhesion. Journal of Endocrinology. 176(2). R1–R7. 80 indexed citations
9.
Rachfal, Amy W.. (2003). Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatology Research. 26(1). 1–9. 215 indexed citations
10.
Park, Hay-Oak, Pil Jung Kang, & Amy W. Rachfal. (2002). Localization of the Rsr1/Bud1 GTPase Involved in Selection of a Proper Growth Site in Yeast. Journal of Biological Chemistry. 277(30). 26721–26724. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026